CN1367255A - Fermentation process for raising ebomycin A yield - Google Patents
Fermentation process for raising ebomycin A yield Download PDFInfo
- Publication number
- CN1367255A CN1367255A CN 02110068 CN02110068A CN1367255A CN 1367255 A CN1367255 A CN 1367255A CN 02110068 CN02110068 CN 02110068 CN 02110068 A CN02110068 A CN 02110068A CN 1367255 A CN1367255 A CN 1367255A
- Authority
- CN
- China
- Prior art keywords
- ebomycin
- fermentation medium
- medium
- liquid
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种提高粘细菌次级代谢产物产量的方法,即提高粘细菌中埃博霉素(Epothilone)产生菌纤维堆囊菌(Sorangium cellulosum)的代谢产物埃博霉素A产量的方法。该方法包括1)对成团生长的粘细菌液体均匀生长的驯化方法,2)适合埃博霉素A产生的地瓜淀粉、水解乳蛋白等的选定以及3)综合地消除产物代谢积累的混合树脂添加方法等步骤,从而使得埃博霉素A产物的产量达到62.7mg/L的水平。
The invention discloses a method for increasing the output of secondary metabolites of myxobacteria, that is, a method for increasing the output of metabolite Epothilone A of Epothilone-producing bacteria Sorangium cellulosum in myxobacteria . The method includes 1) a domestication method for the uniform growth of myxobacteria growing in clusters, 2) selection of sweet potato starch, hydrolyzed milk protein, etc. suitable for epothilone A production, and 3) a mixed method for comprehensively eliminating the metabolic accumulation of products. Resin addition method and other steps, so that the yield of epothilone A product reached the level of 62.7mg/L.
Description
(一)技术领域(1) Technical field
本发明涉及提高粘细菌代谢产物产量的方法,具体地说涉及一种提高粘细菌中纤维堆囊菌的埃博霉素A产量的方法。The invention relates to a method for increasing the yield of metabolites of myxobacteria, in particular to a method for increasing the yield of epothilone A of S. cellulosum in myxobacteria.
(二)背景技术(2) Background technology
目前临床上最为成功的抗肿瘤化疗药物是促微管聚合类天然化合物紫杉醇(paclitaxel,Taxol)及其类似物docetaxel(Taxotere),被用于卵巢癌、胸腺癌、结肠癌、肺癌和肝癌等实体癌的治疗。诱导型抗肿瘤药物紫杉醇的成功及其在化疗中的不足(低水溶性和化疗过程中出现的细胞耐药性等)促使研究人员进一步筛选具有更好的化学性质、生物学性质和药理学性质的微管稳定剂。然而经过长时间、大量的筛选,直到近年才发现了四类新的天然化合物。其中,1993年赫弗勒等报道从粘细菌纤维堆囊菌(Sorangium cellulosum)中分离出新的16元大环内酯类化合物埃博霉素(Epothilone)A和B,在1995年博拉格等在对具有促微管聚合活性的天然化合物大规模筛选中发现埃博霉素的促微管聚合活性后,引起了人们的广泛关注。和紫杉醇相似,埃博霉素可诱导微管蛋白在低温和不含三磷酸鸟苷或微管相关蛋白条件下形成微管。与紫杉醇不同的是,埃博霉素对p-糖蛋白表达型多药抗性细胞株系和肿瘤依然保持活性。另一方面,紫杉醇的内毒素样活性在临床化疗中可能引起非血液性副作用,而埃博霉素不引发细胞的内毒素信号途径。此外,也有研究显示微管稳定剂如紫杉醇或埃博霉素A还具有抗疟活性,能够阻碍裂殖子的形成。At present, the most clinically successful anti-tumor chemotherapy drug is the microtubule polymerization-promoting natural compound paclitaxel (Taxol ® ) and its analogue docetaxel (Taxotere ® ), which are used for ovarian cancer, thymus cancer, colon cancer, lung cancer and liver cancer and other solid cancer treatment. The success of the inducible anti-tumor drug paclitaxel and its shortcomings in chemotherapy (low water solubility and cell drug resistance during chemotherapy, etc.) prompted researchers to further screen for drugs with better chemical, biological and pharmacological properties. microtubule stabilizer. However, after a long time and a lot of screening, it was not until recent years that four new natural compounds were discovered. Among them, in 1993, Hoeffler et al. reported that new 16-membered macrolide compounds Epothilone (Epothilone) A and B were isolated from the myxobacteria Sorangium cellulosum, and in 1995, Bolager After discovering the microtubule polymerization-promoting activity of epothilone in the large-scale screening of natural compounds with microtubule polymerization-promoting activity, it has attracted widespread attention. Like paclitaxel, epothilone induces tubulin to form microtubules at low temperature and in the absence of guanosine triphosphate or microtubule-associated proteins. Unlike paclitaxel, epothilones remain active against p-glycoprotein-expressing multidrug-resistant cell lines and tumors. On the other hand, the endotoxin-like activity of paclitaxel may cause non-hematological side effects in clinical chemotherapy, while epothilone does not trigger the endotoxin signaling pathway of cells. In addition, studies have also shown that microtubule stabilizers such as paclitaxel or epothilone A also have antimalarial activity, which can hinder the formation of merozoites.
埃博霉素较紫杉醇简单的结构、良好的水溶性和极大的药用潜力,使得人们投入了巨大的热情进行研究,以期更快的将其开发成为抗肿瘤药物。化学家们把很多的精力投入到埃博霉素及其类似物的合成和分离上,但是,对于生物法发酵制备埃博霉素,仅见哥特等人的方法(抗生素杂志,1996,49:560-563)。该方法包括能够产生埃博霉素的纤维堆囊菌So ce90菌株,发酵容器为300ml三角瓶,发酵条件为:马铃薯淀粉8g/L,葡萄糖2g/L,脱脂大豆蛋白2g/L,酵母浸汁2g/L,FeNaEDTA 8mg/L,CaCl2.2H2O1g/L,MgSO4.7H2O 1g/L,HEPES 11.5g/L,加入20ml/L的树脂XAD-16。接种后在30℃培养5天。埃博霉素A的产量约为23mg/L。Compared with paclitaxel, epothilone has a simpler structure, good water solubility and great medicinal potential, so that people have invested great enthusiasm in research, in order to develop it into an anti-tumor drug more quickly. Chemists have put a lot of energy into the synthesis and separation of epothilones and their analogues, but for the preparation of epothilones by biological fermentation, only the method of Goth et al. (Journal of Antibiotics, 1996, 49: 560 -563). The method comprises the So ce90 bacterial strain capable of producing epothilone, the fermentation vessel is a 300ml Erlenmeyer flask, and the fermentation conditions are: potato starch 8g/L, glucose 2g/L, defatted soybean protein 2g/L, yeast extract 2g/L, FeNaEDTA 8mg/L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, HEPES 11.5g/L, add 20ml/L resin XAD-16. After inoculation, culture was carried out at 30° C. for 5 days. The yield of epothilone A is about 23mg/L.
上述发酵技术方法的不足在于:1)由于粘细菌在液体中生长时的聚团性质,影响了菌体细胞数量的提高,从而限制了粘细菌代谢产物埃博霉素的产生;2)产生埃博霉素的发酵条件过于复杂,成本较高,并且马铃薯淀粉、葡萄糖、脱脂大豆蛋白和酵母浸汁不是埃博霉素产生的最适碳源和氮源;3)为减少粘细菌代谢产生的埃博霉素对产物的反馈抑制,在发酵过程中添加的XAD-16树脂价格昂贵,并且该种树脂仅能对低极性的代谢产物吸附,对于其他中等极性或高极性的代谢产物的反馈抑制没有作用等。The deficiency of the above-mentioned fermentation technology method is: 1) due to the agglomeration properties of myxobacteria growing in liquid, the improvement of the number of thalline cells is affected, thereby limiting the production of myxobacteria metabolite epothilones; 2) producing epothilones The fermentation conditions of bleomycin are too complicated and the cost is high, and potato starch, glucose, defatted soybean protein and yeast extract are not the most suitable carbon and nitrogen sources for bleomycin production; 3) to reduce the metabolism of myxobacteria Feedback inhibition of epothilone on the product, the XAD-16 resin added during the fermentation process is expensive, and this resin can only adsorb low-polarity metabolites, for other medium-polar or high-polarity metabolites Feedback inhibition has no effect, etc.
针对上述不足,对相关技术和方法进行改进的文献或专利至今未见报道。For above-mentioned deficiencies, the document or the patent of improving related technology and method have not been reported so far.
(三)发明内容(3) Contents of the invention
本发明的目的是针对上述粘细菌发酵产生埃博霉素技术和方法上的不足,提供一种提高埃博霉素A产量的方法,它可以有效地克服现有生产工艺的缺陷,具有产生菌的生长量大,培养条件简单和价格低廉等特点,为在工业生产中应用提供了基础。The purpose of the present invention is to provide a method for improving the yield of epothilone A, which can effectively overcome the defects of the existing production process, and has the advantages of producing epothilones. The characteristics of large growth, simple culture conditions and low price provide a basis for the application in industrial production.
本发明的目的是通过如下的技术方案实现的,具体步骤顺序如下:(1)发酵菌株的选择:粘细菌菌株中纤维堆囊菌(Sorangium cellulosum)ATCC15384,ATCC25531和ATCC25569菌株之一;(2)粘细菌菌株在保持代谢产物合成能力前提下,液体培养均匀生长的驯化:将上述菌株接种在固体斜面培养基上,固体培养基成分为:大豆蛋白胨5~15g/L,马铃薯淀粉15~25g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L,琼脂粉15g/L;30℃,培养5天后,接种至液体发酵培养基,液体发酵培养基成分为:大豆蛋白胨5~15g/L,马铃薯淀粉15~25g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA8mg/L;30℃,120转/分摇床培养5~7天,将上述培养菌重新接回至固体培养基培养,依原条件培养后再接种至液体发酵培养基,如此重复传代驯化,在95~100代时,培养的菌株在液体发酵培养基中的生长呈现适应性的均匀化生长,表现为菌体细胞在液体中由原来的聚团状态变成了均匀生长状态,同时细胞生长的代时缩短,生长量提高,达到最大细胞量的时间由原来的10~12天,缩短至5~7天,获得的最大细胞量由原来的1~4×108细胞/ml,增加到5~10×109细胞/ml;(3)发酵培养条件的优化:将步骤(2)均匀化生长的菌株接种至固体培养基,固体培养基成分同上,30℃,培养5天后,接种至含有树脂的液体发酵培养基,液体发酵培养基的成分为:碳源是地瓜淀粉、马铃薯淀粉、葡聚寡糖、木聚糖之一,浓度均为20g/L,氮源是水解乳蛋白、大豆蛋白胨、酒石酸铵、柠檬酸铵之一,浓度均为10g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L,树脂选择XAD-16,添加量为20ml/L;发酵容器为500ml三角瓶,内含200ml液体发酵培养基,培养温度为30℃,摇床转速为120转/分,培养5~7天;(4)综合消除代谢产物对菌株产生埃博霉素的影响:将上述菌株接种至固体培养基,固体培养基成分同上,30℃,培养5天后,接种至含有树脂的液体发酵培养基,液体发酵培养基的成分为地瓜淀粉20g/L,水解乳蛋白10g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O1g/L,Fe-EDTA 8mg/L,树脂选择XDA,AB-8或混合树脂之一,添加量为10~40ml/L;发酵容器为500ml三角瓶,内含200ml液体发酵培养基,培养温度为30℃,摇床转速为120转/分,培养6~7天;(5)埃博霉素A的分离提取纯化:发酵结束后,将液体发酵培养基中添加的树脂取出,经甲醇浸提,浸提物再经过离子交换,分子筛和高效液相提取纯化,即得到埃博霉素A。The object of the present invention is achieved through the following technical solutions, and the sequence of specific steps is as follows: (1) selection of fermentation strains: one of Sorangium cellulosum ATCC15384, ATCC25531 and ATCC25569 bacterial strains in myxobacteria strains; On the premise of maintaining the ability to synthesize metabolites, the myxobacteria strains can be domesticated in liquid culture for uniform growth: the above strains are inoculated on a solid slant medium, and the composition of the solid medium is: soybean peptone 5-15g/L, potato starch 15-25g/L L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L, Agar powder 15g/L; The components of the fermentation medium are: soybean peptone 5~15g/L,
其中步骤(1)所述的发酵菌株选择纤维堆囊菌(Sorangium cellulosum)ATCC15384。Wherein the fermentation strain described in the step (1) is selected from Sorangium cellulosum (Sorangium cellulosum) ATCC15384.
其中步骤(2)所述的固体培养基成分为:大豆蛋白胨8g/L,马铃薯淀粉20g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L,琼脂粉15g/L。Wherein the solid medium composition described in step (2) is: soybean peptone 8g/L, potato starch 20g/L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg /L, agar powder 15g/L.
其中步骤(2)所述的液体发酵培养基成分为:大豆蛋白胨10g/L,马铃薯淀粉21g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L。Wherein the liquid fermentation medium composition described in step (2) is: soybean peptone 10g/L, potato starch 21g/L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L.
其中步骤(3)所述的液体发酵培养基的成分中碳源是地瓜淀粉。Wherein the carbon source in the composition of the liquid fermentation medium described in step (3) is sweet potato starch.
其中步骤(3)所述的液体发酵培养基的成分中氮源是水解乳蛋白。Wherein the nitrogen source in the composition of the liquid fermentation medium described in step (3) is hydrolyzed milk protein.
其中步骤(4)所述混合树脂的添加量为20ml/L。Wherein the addition amount of the mixed resin described in step (4) is 20ml/L.
其中步骤(4)所述混合树脂是指CD180,CAD-40,XDA,S-8,NKA-II,AB-8六种树脂按重量比0.8~1.2∶0.8~1.2∶1.8~2.2∶0.8~1.2∶2.8~3.2∶1.8~2.2混合。Wherein step (4) described mixed resin refers to CD180, CAD-40, XDA, S-8, NKA-II, six kinds of resins of AB-8 by weight ratio 0.8~1.2: 0.8~1.2: 1.8~2.2: 0.8~ 1.2: 2.8-3.2: 1.8-2.2 mixed.
其中步骤(4)所述混合树脂是指CD180,CAD-40,XDA,S-8,NKA-II,AB-8六种树脂按重量比1∶1∶2∶1∶3∶2混合。Wherein the mixed resin in step (4) refers to the six resins CD180, CAD-40, XDA, S-8, NKA-II, and AB-8 mixed in a weight ratio of 1:1:2:1:3:2.
将上述发酵液中添加的混合树脂取出,加10倍体积甲醇浸提,浸提物经过离子交换,分子筛和高效液相纯化。纯化得到的化合物,分别测定了质谱(见附图1),紫外谱图(见附图2)和核磁共振谱图(见附图3和4),确认了埃博霉素(Epothilone)A结构(附图5)。Take out the mixed resin added in the fermentation broth, add 10 times the volume of methanol to extract, and the extract is purified by ion exchange, molecular sieve and high performance liquid phase. The compound that purification obtains has measured mass spectrometry (see accompanying drawing 1) respectively, and ultraviolet spectrogram (seeing accompanying drawing 2) and NMR spectrogram (seeing accompanying
表1的结果显示了菌株液体均匀生长驯化后的埃博霉素A产量。本项技术的创造性在于:1)通过液体均匀生长驯化方法,改变粘细菌生长的成团性质,从而提高菌体的生长细胞密度,并且菌体细胞的生长代时缩短,缩短了发酵周期;2)该方法是以发酵培养基为驯化生长培养基,从而使得液体均匀生长的菌株对发酵培养基有更好的适应性,避免了驯化菌株丢失埃博霉素产生能力的情况。本项技术获得的结果是均匀生长的菌株产生埃博霉素A的产量是成团生长的野生菌株的三倍。表1The results in Table 1 show the epothilone A production of the strain after liquid uniform growth and acclimatization. The creativity of this technology lies in: 1) through the uniform growth and domestication method of the liquid, the agglomeration property of the growth of myxobacteria is changed, thereby increasing the growth cell density of the bacteria, and the growth generation time of the bacteria cells is shortened, shortening the fermentation cycle; 2 ) The method uses the fermentation medium as the domestication growth medium, so that the strains grown evenly in the liquid have better adaptability to the fermentation medium, and avoid the situation that the domestication strains lose the ability to produce epothilones. The result obtained by this technology is that the yield of epothilone A produced by the uniformly grown strain is three times that of the wild strain grown in clumps. Table 1
菌株 原始菌株 液体均匀生长驯化菌株埃博霉素A(mg/L) 12.3 33.7 Strain
表2是不同碳源对液体均匀生长驯化菌株的埃博霉素A合成的影响。其中地瓜淀粉、马铃薯淀粉、葡聚寡糖、木聚糖、葡萄糖等对埃博霉素A的产生具有明显的促进作用。表2Table 2 is the effect of different carbon sources on the epothilone A synthesis of liquid uniform growth acclimatized strains. Among them, sweet potato starch, potato starch, oligodextran, xylan, glucose, etc. can significantly promote the production of epothilone A. Table 2
浓度 埃博霉素A 浓度 埃博霉素AConcentration Epothilone A Concentration Epothilone A
碳源 碳源carbon source carbon source
(g/L) (mg/L) (g/L) (mg/L)地瓜淀粉 20 49.5 葡萄糖 8 33.6
表3是不同氮源对液体均匀生长驯化菌株的埃博霉素A合成的影响。其中水解乳蛋白、大豆蛋白胨、酒石酸铵、柠檬酸铵、脱脂奶粉等对埃博霉素A的产生具有明显的促进作用。表3
表2和表3的结果获得的地瓜淀粉和水解乳蛋白比文献培养基条件高15~25%的埃博霉素A的产量。本项技术的创造性在于:获得的培养基条件比文献的培养基条件所产生的埃博霉素A产量高,同时培养基成分的来源更为便宜易得,为工业化发酵奠定了基础。The yield of sweet potato starch and hydrolyzed milk protein obtained from the results of Table 2 and Table 3 is 15-25% higher than that of literature culture medium. The creativity of this technology lies in that the obtained culture medium conditions are higher than the culture medium conditions in the literature to produce higher yields of epothilone A, and at the same time, the sources of the culture medium components are cheaper and easier to obtain, which lays the foundation for industrial fermentation.
表4是在发酵不同树脂对埃博霉素A合成的影响。结果显示这些国产的树脂能够有效地吸附埃博霉素A,其中XDA、AB-8和几种树脂的等比例混合的效果较好。表4
表5是混合树脂加量对埃博霉素A合成的影响。其中10ml/L到40ml/L的效果较好。Table 5 is the effect of the amount of mixed resin added on the synthesis of epothilone A. Among them, the effect of 10ml/L to 40ml/L is better.
表5table 5
混合树脂(ml/L) 埃博霉素A(mg/L) Mixed Resin (ml/L) Epothilone A (mg/L)
0 12.50 12.5
10 43.710 43.7
20 63.220 63.2
40 37.740 37.7
70 31.070 31.0
表4和表5的结果不但获得了与XAD-16相当或更高的埃博霉素A产量,而且所使用的树脂均为廉价的国产树脂,从而降低了生产成本,从而具有更好的工业化可行性。此外,采用混合树脂的思路,不但降低了埃博霉素对代谢途径的反馈抑制,而且也同时降低了其他代谢产物对产生菌的代谢的反馈抑制,从而从总体上提高了菌体的代谢能力,并为进一步提高埃博霉素A的产量提供可能性。The results of Table 4 and Table 5 not only obtained the equivalent or higher epothilone A yield with XAD-16, but also the resins used are cheap domestic resins, thereby reducing production costs and thus having better industrialization feasibility. In addition, the idea of using mixed resins not only reduces the feedback inhibition of epothilone on the metabolic pathway, but also reduces the feedback inhibition of other metabolites on the metabolism of the producing bacteria, thus improving the metabolic capacity of the bacteria as a whole , and provide the possibility to further increase the production of epothilone A.
(四)附图说明:图1提纯得到的埃博霉素A的质谱谱图(4) Description of drawings: the mass spectrogram of the epothilone A that Fig. 1 purifies
图中所示,样品为提纯后的埃博霉素A,得出组分的(M+H)+为494.2561,拟合化合物的分子式为C26H39O6NS,相对偏差1.922e-06;与埃博霉素A的理论值完全吻合。图2提纯得到的埃博霉素A的紫外光谱图图3提纯得到的埃博霉素A的PMR谱图图4提纯得到的埃博霉素A的13C-NMR谱图图5埃博霉素(Epothilone)A的化学结构As shown in the figure, the sample is purified epothilone A, the (M+H) + of the component is 494.2561, the molecular formula of the fitted compound is C 26 H 39 O 6 NS, and the relative deviation is 1.922e-06 ; in perfect agreement with the theoretical value of epothilone A. Fig. 2 The UV spectrum of the purified epothilone A Fig. 3 The PMR spectrum of the purified epothilone A Fig. 4 The 13 C-NMR spectrum of the purified epothilone A Fig. 5 Epothilone Chemical Structure of Epothilone A
(五)具体实施方式(5) Specific implementation methods
实施例1:(1)发酵菌株选择粘细菌菌株中纤维堆囊菌(Sorangium cellulosum)ATCC15384。(2)粘细菌菌株在保持代谢产物合成能力前提下,液体培养均匀生长的驯化:将上述菌株接种在固体斜面培养基上,固体培养基成分为:大豆蛋白胨8g/L,马铃薯淀粉20g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L,琼脂粉15g/L;30℃,培养5天后,接种至液体发酵培养基,液体发酵培养基成分为:大豆蛋白胨10g/L,马铃薯淀粉20g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L;30℃,120转/分摇床培养7天,将上述培养菌重新接回至固体培养基培养,依原条件培养后再接种至液体发酵培养基,如此重复传代驯化,在100代时,培养的菌株在液体发酵培养基中的生长呈现适应性的均匀化生长,表现为菌体细胞在液体中由原来的聚团状态变成了均匀生长状态,达到最大细胞量的时间由原来的11天缩短至6天,获得的最大细胞量由原来的4×108细胞/ml,增加到10×109细胞/ml;(3)发酵培养条件的优化:将步骤(2)均匀化生长的菌株接种至固体培养基,固体培养基成分同上,30℃,培养5天后,接种至含有树脂的液体发酵培养基,液体发酵培养基的成分为:碳源是地瓜淀粉、,浓度为20g/L,氮源是水解乳蛋白,浓度为10g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L,树脂是D-16,添加量为20ml/L;发酵容器为500ml三角瓶,内含200ml液体发酵培养基,培养温度为30℃,摇床转速为120转/分,培养7天;(4)综合消除代谢产物对菌株产生埃博霉素的影响:将上述菌株接种至固体培养基,固体培养基成分同上,30℃,培养5天后,接种至含有树脂的液体发酵培养基,液体发酵培养基的成分为地瓜淀粉20g/L,水解乳蛋白10g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O1g/L,Fe-EDTA 8mg/L,树脂选择混合树脂,添加量为20ml/L;混合树脂由CD180,CAD-40,XDA,S-8,NKA-II,AB-8六种树脂按重量比1∶1∶2∶1∶3∶2混合而成,发酵容器为500ml三角瓶,内含200ml液体发酵培养基,培养温度为30℃,摇床转速为120转/分,培养7天;(5)埃博霉素A的分离提取纯化:发酵结束后,将液体发酵培养基中添加的树脂取出,加10倍体积甲醇浸提,浸提物再经过离子交换,分子筛和高效液相提取纯化,获到埃博霉素A的产量为66.7mg/L。Example 1: (1) Fermentation strain Sorangium cellulosum (Sorangium cellulosum) ATCC15384 among myxobacteria strains was selected. (2) Under the premise of maintaining the synthesis ability of metabolites, the myxobacteria strains are domesticated by liquid culture and uniform growth: the above-mentioned strains are inoculated on a solid slant medium, and the solid medium components are: soybean peptone 8g/L, potato starch 20g/L , CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L, agar powder 15g/L; 30°C, after 5 days of cultivation, inoculated into liquid fermentation medium, liquid fermentation The medium components are: soybean peptone 10g/L, potato starch 20g/L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L; 30°C, 120 rpm Cultivate in a shaking table for 7 days, reconnect the above-mentioned cultured bacteria to the solid medium for cultivation, cultivate them according to the original conditions and then inoculate them into the liquid fermentation medium. The growth in the medium showed adaptive homogeneous growth, which showed that the bacterial cells changed from the original aggregated state to the uniform growth state in the liquid, and the time to reach the maximum cell mass was shortened from the original 11 days to 6 days. The maximum cell amount increased from the original 4×10 8 cells/ml to 10×10 9 cells/ml; (3) Optimization of fermentation culture conditions: Inoculate the homogenized strains grown in step (2) into solid medium, The composition of the solid medium is the same as above, 30°C, after 5 days of cultivation, inoculate into the liquid fermentation medium containing resin, the composition of the liquid fermentation medium is: the carbon source is sweet potato starch, the concentration is 20g/L, and the nitrogen source is hydrolyzed milk protein , the concentration is 10g/L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L, the resin is D-16, the addition amount is 20ml/L; the fermentation vessel is 500ml Erlenmeyer flask, containing 200ml liquid fermentation medium, culture temperature is 30 ℃, shaking table speed is 120 rev/min, cultivates for 7 days; (4) comprehensively eliminates the influence of metabolites on bacterial strain producing epothilone: combine the above The strain was inoculated into a solid medium, the composition of which was the same as above, at 30°C, and after 5 days of cultivation, it was inoculated into a liquid fermentation medium containing resin. The composition of the liquid fermentation medium was sweet potato starch 20g/L, hydrolyzed milk protein 10g/L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L, resin selection mixed resin, the addition amount is 20ml/L; mixed resin consists of CD180, CAD-40, XDA, S -8, NKA-II, AB-8 six kinds of resins are mixed by weight ratio 1: 1: 2: 1: 3: 2, and the fermentation vessel is a 500ml triangular flask containing 200ml liquid fermentation medium, and the cultivation temperature is 30 ℃, shaker speed is 120 rev/min, cultivated for 7 days; (5) Separation, extraction and purification of epothilone A: after the fermentation, the resin added in the liquid fermentation medium was taken out, and 10 times the volume of methanol was added to extract , the extract was purified by ion exchange, molecular sieve and high-performance liquid phase extraction, and the yield of epothilone A was 66.7mg/L.
实施例2:(1)发酵菌株选择粘细菌菌株中纤维堆囊菌(Sorangium cellulosum)ATCC15384。(2)粘细菌菌株在保持代谢产物合成能力前提下,液体培养均匀生长的驯化:将上述菌株接种在固体斜面培养基上,固体培养基成分为:大豆蛋白胨10g/L,马铃薯淀粉22g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L,琼脂粉15g/L;30℃,培养5天后,接种至液体发酵培养基,液体发酵培养基成分为:大豆蛋白胨12g/L,马铃薯淀粉23g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L;30℃,120转/分摇床培养5天,将上述培养菌重新接回至固体培养基培养,依原条件培养后再接种至液体发酵培养基,如此重复传代驯化,在96代时,培养的菌株在液体发酵培养基中的生长呈现适应性的均匀化生长,表现为菌体细胞在液体中由原来的聚团状态变成了均匀生长状态,达到最大细胞量的时间由原来的10天缩短至5天,获得的最大细胞量由原来的2×108细胞/ml,增加到7×109细胞/ml;(3)发酵培养条件的优化:将步骤(2)均匀化生长的菌株接种至固体培养基,固体培养基成分同上,30℃,培养5天后,接种至含有树脂的液体发酵培养基,液体发酵培养基的成分为:碳源是马铃薯淀粉、,浓度为20g/L,氮源是大豆蛋白胨,浓度为10g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L,树脂是D-16,添加量为20ml/L;发酵容器为500ml三角瓶,内含200ml液体发酵培养基,培养温度为30℃,摇床转速为120转/分,培养5天;(4)综合消除代谢产物对菌株产生埃博霉素的影响:将上述菌株接种至固体培养基,固体培养基成分同上,30℃,培养5天后,接种至含有树脂的液体发酵培养基,液体发酵培养基的成分为地瓜淀粉20g/L,水解乳蛋白10g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O1g/L,Fe-EDTA 8mg/L,树脂选择XDA,添加量为20ml/L;发酵容器为500ml三角瓶,内含200ml液体发酵培养基,培养温度为30℃,摇床转速为120转/分,培养6天;(5)埃博霉素A的分离提取纯化:发酵结束后,将液体发酵培养基中添加的树脂取出,加10倍体积甲醇浸提,浸提物再经过离子交换,分子筛和高效液相提取纯化,获到埃博霉素A的产量为66.3mg/L。Example 2: (1) Sorangium cellulosum (Sorangium cellulosum) ATCC15384 among the myxobacteria strains was selected for fermentation. (2) Under the premise of maintaining the synthesis ability of metabolites, the myxobacteria strains are domesticated by liquid culture and uniform growth: the above-mentioned strains are inoculated on a solid slant medium, and the solid medium components are: soybean peptone 10g/L, potato starch 22g/L , CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L, agar powder 15g/L; 30°C, after 5 days of cultivation, inoculated into liquid fermentation medium, liquid fermentation The medium components are: soybean peptone 12g/L, potato starch 23g/L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L; 30°C, 120 rpm Cultivate in a shaking table for 5 days, reconnect the above-mentioned cultured bacteria to the solid medium for cultivation, cultivate them according to the original conditions, and then inoculate them into the liquid fermentation medium, repeat the subculture and acclimatization in this way, and at the 96th generation, the cultured strains were cultured in the liquid fermentation culture. The growth in the medium showed adaptive homogeneous growth, which showed that the bacterial cells changed from the original aggregated state to the uniform growth state in the liquid, and the time to reach the maximum cell mass was shortened from the original 10 days to 5 days. The maximum cell amount increased from 2×10 8 cells/ml to 7×10 9 cells/ml; (3) Optimization of fermentation culture conditions: inoculate the homogenized strains grown in step (2) into solid medium, The composition of the solid medium is the same as above, at 30°C, after cultivating for 5 days, inoculate into the liquid fermentation medium containing resin, the composition of the liquid fermentation medium is: the carbon source is potato starch, the concentration is 20g/L, the nitrogen source is soybean peptone, The concentration is 10g/L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L, the resin is D-16, the addition amount is 20ml/L; the fermentation vessel is 500ml Erlenmeyer flask, containing 200ml liquid fermentation medium, culture temperature is 30 ℃, shaker speed is 120 rev/min, cultivate 5 days; (4) comprehensively eliminate the influence of metabolites on bacterial strain producing epothilone: the above bacterial strain Inoculate into a solid medium with the same composition as above, at 30°C. After culturing for 5 days, inoculate into a liquid fermentation medium containing resin. The components of the liquid fermentation medium are sweet potato starch 20g/L, hydrolyzed milk protein 10g/L, CaCl 2.2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L, choose XDA as the resin, add 20ml/L; the fermentation vessel is a 500ml Erlenmeyer flask containing 200ml liquid fermentation medium , the culture temperature is 30°C, the shaker speed is 120 rev/min, and cultivated for 6 days; (5) Separation, extraction and purification of epothilone A: after the fermentation, the resin added in the liquid fermentation medium is taken out, and 10 Double the volume of methanol leaching, the extract was purified by ion exchange, molecular sieve and high performance liquid phase extraction, and the yield of epothilone A was 66.3mg/L.
实施例3:(1)发酵菌株选择粘细菌菌株中纤维堆囊菌(Sorangium cellulosum)ATCC15384。(2)粘细菌菌株在保持代谢产物合成能力前提下,液体培养均匀生长的驯化:将上述菌株接种在固体斜面培养基上,固体培养基成分为:大豆蛋白胨6g/L,马铃薯淀粉17g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L,琼脂粉15g/L;30℃,培养5天后,接种至液体发酵培养基,液体发酵培养基成分为:大豆蛋白胨7g/L,马铃薯淀粉17g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L;30℃,120转/分摇床培养7天,将上述培养菌重新接回至固体培养基培养,依原条件培养后再接种至液体发酵培养基,如此重复传代驯化,在98代时,培养的菌株在液体发酵培养基中的生长呈现适应性的均匀化生长,表现为菌体细胞在液体中由原来的聚团状态变成了均匀生长状态,达到最大细胞量的时间由原来的12天缩短至7天,获得的最大细胞量由原来的2×108细胞/ml,增加到5×109细胞/ml;(3)发酵培养条件的优化:将步骤(2)均匀化生长的菌株接种至固体培养基,固体培养基成分同上,30℃,培养5天后,接种至含有树脂的液体发酵培养基,液体发酵培养基的成分为:碳源是葡聚寡糖、,浓度为20g/L,氮源是酒石酸铵,浓度为10g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O 1g/L,Fe-EDTA 8mg/L,树脂是D-16,添加量为20ml/L;发酵容器为500ml三角瓶,内含200ml液体发酵培养基,培养温度为30℃,摇床转速为120转/分,培养7天;(4)综合消除代谢产物对菌株产生埃博霉素的影响:将上述菌株接种至固体培养基,固体培养基成分同上,30℃,培养5天后,接种至含有树脂的液体发酵培养基,液体发酵培养基的成分为地瓜淀粉20g/L,水解乳蛋白10g/L,CaCl2.2H2O 1g/L,MgSO4.7H2O1g/L,Fe-EDTA 8mg/L,树脂选择AB-8,添加量为20ml/L;发酵容器为500ml三角瓶,内含200ml液体发酵培养基,培养温度为30℃,摇床转速为120转/分,培养5天;(5)埃博霉素A的分离提取纯化:发酵结束后,将液体发酵培养基中添加的树脂取出,加10倍体积甲醇浸提,浸提物再经过离子交换,分子筛和高效液相提取纯化,获到埃博霉素A的产量为65.4mg/L。Example 3: (1) Fermentation strain Sorangium cellulosum (Sorangium cellulosum) ATCC15384 among myxobacteria strains was selected. (2) Under the premise of maintaining the synthesis ability of metabolites, the myxobacteria strains are acclimated to uniform growth in liquid culture: inoculate the above-mentioned strains on a solid slant medium, and the components of the solid medium are: soybean peptone 6g/L, potato starch 17g/L , CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L, agar powder 15g/L; 30°C, after 5 days of cultivation, inoculated into liquid fermentation medium, liquid fermentation The medium components are: soybean peptone 7g/L, potato starch 17g/L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L; 30°C, 120 rpm Cultivate in a shaking table for 7 days, reconnect the above-mentioned cultured bacteria to the solid medium for cultivation, cultivate them according to the original conditions, and then inoculate them into the liquid fermentation medium, repeat the subculture and acclimatization in this way, and at the 98th generation, the cultured strains will be cultured in the liquid fermentation culture. The growth in the medium showed adaptive homogeneous growth, which showed that the bacterial cells changed from the original aggregated state to the uniform growth state in the liquid, and the time to reach the maximum cell mass was shortened from the original 12 days to 7 days. The maximum cell amount increased from 2×10 8 cells/ml to 5×10 9 cells/ml; (3) Optimization of fermentation culture conditions: inoculate the homogenized strains grown in step (2) into solid medium, The composition of the solid medium is the same as above, 30°C, after culturing for 5 days, inoculate into the liquid fermentation medium containing resin, the composition of the liquid fermentation medium is: the carbon source is dextran oligosaccharide, the concentration is 20g/L, and the nitrogen source is tartaric acid Ammonium, the concentration is 10g/L, CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L, resin is D-16, the addition amount is 20ml/L; fermentation vessel It is a 500ml Erlenmeyer flask containing 200ml liquid fermentation medium. The culture temperature is 30°C, the shaking table speed is 120 rpm, and cultivated for 7 days; (4) comprehensively eliminate the influence of metabolites on the production of epothilones by The above-mentioned strains were inoculated into a solid medium with the same composition as above, at 30°C, cultured for 5 days, and then inoculated into a liquid fermentation medium containing resin. The composition of the liquid fermentation medium was sweet potato starch 20g/L, hydrolyzed milk protein 10g/L , CaCl 2 .2H 2 O 1g/L, MgSO 4 .7H 2 O 1g/L, Fe-EDTA 8mg/L, resin selection AB-8, the addition amount is 20ml/L; the fermentation vessel is a 500ml Erlenmeyer flask containing 200ml Liquid fermentation medium, culture temperature is 30 ℃, shaker speed is 120 rev/min, cultivate for 5 days; (5) Separation, extraction and purification of epothilone A: after the fermentation, the resin added in the liquid fermentation medium Take it out, add 10 times the volume of methanol to extract, and the extract is purified by ion exchange, molecular sieve and high-performance liquid phase extraction, and the yield of epothilone A is 65.4mg/L.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02110068 CN1212404C (en) | 2002-02-07 | 2002-02-07 | A kind of fermentation technology method that improves epothilone A output |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02110068 CN1212404C (en) | 2002-02-07 | 2002-02-07 | A kind of fermentation technology method that improves epothilone A output |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1367255A true CN1367255A (en) | 2002-09-04 |
| CN1212404C CN1212404C (en) | 2005-07-27 |
Family
ID=4740919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02110068 Expired - Fee Related CN1212404C (en) | 2002-02-07 | 2002-02-07 | A kind of fermentation technology method that improves epothilone A output |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1212404C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1312286C (en) * | 2005-10-19 | 2007-04-25 | 华南理工大学 | Method for highly-effective producing epothilone using myxobacteria sorangium cellulosum |
| CN101126073B (en) * | 2007-07-02 | 2011-09-07 | 江南大学 | Sorangium cellulosum, preparation method and application for Phoxalone fermented by the same |
| CN101643490B (en) * | 2008-08-07 | 2012-10-03 | 浙江海正药业股份有限公司 | Epothilonoside compound, preparation method and application as cytostatics thereof |
| CN103088084A (en) * | 2013-01-30 | 2013-05-08 | 广州市微生物研究所 | Method for preparing epothilone by inducing sorangium cellulosum expression |
| CN105200093A (en) * | 2015-11-09 | 2015-12-30 | 山东大学 | Fermentation additive capable of changing generation rate of epothilone compound and improving yield of epothilone A |
| CN105200090A (en) * | 2015-11-12 | 2015-12-30 | 山东大学 | Culture medium for preparing epothilone through fermenting myxococcus Xanthus for heterologously expressing epothilone gene |
-
2002
- 2002-02-07 CN CN 02110068 patent/CN1212404C/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1312286C (en) * | 2005-10-19 | 2007-04-25 | 华南理工大学 | Method for highly-effective producing epothilone using myxobacteria sorangium cellulosum |
| CN101126073B (en) * | 2007-07-02 | 2011-09-07 | 江南大学 | Sorangium cellulosum, preparation method and application for Phoxalone fermented by the same |
| CN101643490B (en) * | 2008-08-07 | 2012-10-03 | 浙江海正药业股份有限公司 | Epothilonoside compound, preparation method and application as cytostatics thereof |
| CN103088084A (en) * | 2013-01-30 | 2013-05-08 | 广州市微生物研究所 | Method for preparing epothilone by inducing sorangium cellulosum expression |
| CN103088084B (en) * | 2013-01-30 | 2014-10-29 | 广州市微生物研究所 | Method for preparing epothilone by inducing sorangium cellulosum expression |
| CN105200093A (en) * | 2015-11-09 | 2015-12-30 | 山东大学 | Fermentation additive capable of changing generation rate of epothilone compound and improving yield of epothilone A |
| CN105200093B (en) * | 2015-11-09 | 2018-08-03 | 山东大学 | A kind of additives for ferment that can change epothilones generation ratio and improve ebomycin A yield |
| CN105200090A (en) * | 2015-11-12 | 2015-12-30 | 山东大学 | Culture medium for preparing epothilone through fermenting myxococcus Xanthus for heterologously expressing epothilone gene |
| CN105200090B (en) * | 2015-11-12 | 2018-08-03 | 山东大学 | A kind of Myxococcus xanthus fermentation for heterogenous expression Epothilones gene prepares the culture medium of Epothilones |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1212404C (en) | 2005-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | Self-assembly of bio-cellulose nanofibrils through intermediate phase in a cell-free enzyme system | |
| CN1082543C (en) | Polycyclic antiparasitic agents, process and strain for their preparation and their use | |
| CN1264967C (en) | Industrial use of marine fungus fission chytrid OUC88 | |
| CN102864111B (en) | Schizochytrium limacinum strain for producing docosahexaenoic acid | |
| CN103224965B (en) | Method for producing pyrroloquinoline quinine through microbial fermentation and fermentation medium used in same | |
| CN101831481B (en) | New method for preparing Iturin A and homolugues thereof | |
| CN113174344B (en) | Strain for producing tunicacidin B and application thereof | |
| CN1367255A (en) | Fermentation process for raising ebomycin A yield | |
| CN111057669A (en) | Strain for improving yield of tetramycin Z and method for preparing tetramycin Z by using same | |
| CN1840684A (en) | Method for producing nosipeptide by fermenting streptomyces | |
| CN1141392C (en) | Process for preparing ganoderic polyose and ganoderic acid by fermentation during which raw materials are supplemented | |
| CN108277170B (en) | New mycobacterium aureofaciens and application thereof in preparation of 9-hydroxyprogesterone | |
| US9546197B2 (en) | Method for preparing cyclic lipopeptide compound | |
| CN100338226C (en) | Method for preparing 11 alpha bydroxy canrenone through conversion method of batch fermentation of microbe | |
| CN101457250B (en) | Method for synthesizing betulinic acid by microbial cell biotransformation of betulin | |
| CN1312286C (en) | Method for highly-effective producing epothilone using myxobacteria sorangium cellulosum | |
| CN107365811A (en) | Utilize the technique of actinoplanes fermenting and producing rapamycin | |
| CN1928101A (en) | Method for preparing conjugated linoleic acid | |
| CN108277243B (en) | Preparation method of pseudomonic acid A | |
| CN101078005A (en) | Bacillus pumilus and application of the same in producing natural vanillin by biologically converting iso-eugenol | |
| CN117448174A (en) | A mangrove sediment-derived fungus and its application | |
| CN103725728A (en) | Preparation method for Bacillamide compound and Bacillamide precursor | |
| CN102757443A (en) | Sulfur-substituted podophyllum derivative and bioconversion, separation and purification method thereof | |
| CN1670185A (en) | A kind of mycobacterium fortuitous and its application in the production of testosterone by microbial transformation | |
| CN114381386A (en) | Culture medium for producing abamectin by fermentation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |